These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26390039)

  • 1. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy.
    Xu W; Thapa R; Liu D; Nissinen T; Granroth S; Närvänen A; Suvanto M; Santos HA; Lehto VP
    Mol Pharm; 2015 Nov; 12(11):4038-47. PubMed ID: 26390039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
    Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
    Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
    Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapy.
    Zhu C; Xiao J; Tang M; Feng H; Chen W; Du M
    Int J Nanomedicine; 2017; 12():3697-3710. PubMed ID: 28553108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination.
    Feng L; Wang Y; Luo Z; Huang Z; Zhang Y; Guo K; Ye D
    Chemistry; 2017 Jul; 23(39):9397-9406. PubMed ID: 28489292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 12. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
    Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
    J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.
    Tamarov K; Xu W; Osminkina L; Zinovyev S; Soininen P; Kudryavtsev A; Gongalsky M; Gaydarova A; Närvänen A; Timoshenko V; Lehto VP
    J Control Release; 2016 Nov; 241():220-228. PubMed ID: 27686581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
    Asghar K; Qasim M; Dharmapuri G; Das D
    Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.